Motoneuron excitability in Parkinson’s disease: effects of dopaminergic medication
Journal of Neurophysiology · 2026
DOI: 10.1152/jn.00614.2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurophysiology, 2026. Verfasst von Parisa Alaei und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health and Social Development, University of British Columbia Okanagan, Kelowna, British Columbia, Canada. Hauptthemen laut MEDLINE: Parkinson Disease, Motor Neurons, Dopamine Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Natural Sciences and Engineering Research Council of Canada (NSERC), European Union's Horizon Europe Research and Innovation Program, The Slovenian Research and Innovation Agency (ARRS).
Abstract (Originalsprache)
This study provides new evidence that motoneuron excitability is consistently elevated in people with Parkinson’s disease (PD) independent of dopaminergic medication. People with PD showed higher initial discharge rates, lower recruitment thresholds, and greater indicators of persistent inward currents than controls, pointing to lasting spinal adaptations driven by chronic monoaminergic deficits. The persistence of these abnormalities despite dopamine replacement therapy indicates that chronic monoaminergic depletion produces enduring plasticity within the spinal circuits that persists despite dopamine replacement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Health and Social Development, University of British Columbia Okanagan, Kelowna, British Columbia, Canada.
- Healthy Exercise and Aging Laboratory, Aging in Place Research Cluster, University of British Columbia Okanagan, Kelowna, British Columbia, Canada.
- School of Human Kinetics and Recreation, Memorial University of Newfoundland, St. John's, Newfoundland, Canada.
- Centre for Chronic Disease Prevention and Management, University of British Columbia Okanagan, Kelowna, British Columbia, Canada.
- Faculty of Electrical Engineering and Computer Science, University of Maribor, Maribor, Slovenia.
ORCID-Profile: Gregory E P Pearcey, Daryl J Wile, Aleš Holobar, Jennifer M Jakobi
Förderung
- Natural Sciences and Engineering Research Council of Canada (NSERC)
- European Union's Horizon Europe Research and Innovation Program
- The Slovenian Research and Innovation Agency (ARRS)
- European Union’s Horizon Europe Research and Innovation Program
Zitieren
APA
Alaei, P., Pearcey, G. E. P., Wile, D. J., Holobar, A., & Jakobi, J. M. (2026). Motoneuron excitability in Parkinson’s disease: effects of dopaminergic medication. Journal of Neurophysiology. https://doi.org/10.1152/jn.00614.2025
Vancouver
Alaei P, Pearcey GEP, Wile DJ, Holobar A, Jakobi JM. Motoneuron excitability in Parkinson’s disease: effects of dopaminergic medication. Journal of Neurophysiology. 2026. doi:10.1152/jn.00614.2025
BibTeX
@article{Alaei2026,
author = {Alaei, Parisa and Pearcey, Gregory E P and Wile, Daryl J and Holobar, Aleš and Jakobi, Jennifer M},
title = {Motoneuron excitability in Parkinson’s disease: effects of dopaminergic medication},
journal = {Journal of Neurophysiology},
year = {2026},
doi = {10.1152/jn.00614.2025}
}
EUVIMED